Login to Your Account



New Irish Institute Formed To Focus On Trials Of Orphan Drugs

By Cormac Sheridan


Wednesday, June 11, 2003
CORK, Ireland - Bristol-Myers Squibb Co., Pfizer Inc. and the Irish government are the initial backers of a new not-for-profit institute at University College Cork (UCC) that aims to establish a pan-European network specializing in conducting clinical trials of products that have received orphan designation. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription